Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry
- Creator: Gibson, P. G. , Reddel, H. , Katsoulotos, G. P. , Cook, M. , Yang, I. , Katelaris, C. , Bowler, S. , Langton, D. , Robinson, P. , Wright, C. , Yozghatlian, V. , Burgess, S. , McDonald, V. M. , Sivakumaran, P. , Jaffe, A. , Bowden, J. , Wark, P. A. B. , Yan, K. Y. , Kritikos, V. , Peters, M. , Hew, M. , Aminazad, A. , Bint, M. , Marks, G. , Guo, M. , Jenkins, C. , Gillman, A. , Upham, J. , Sutherland, M. , Rimmer, J. , Thien, F.
- Resource Type: journal article
- Date: 2016
Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria
- Creator: Hew, M. , Gillman, A. , Rimmer, J. , Katsoulotos, G. P. , Cook, M. , Yang, I. , Katelaris, C. , Bowler, S. , Langton, D. , Wright, C. , Bint, M. , Yozghatlian, V. , Sutherland, M. , Powell, H. , McDonald, V. M. , Gibson, P. G. , Wark, P. , Bowden, J. , Guo, M. , Reddel, H. K. , Jenkins, C. , Marks, G. B. , Thien, F.
- Resource Type: journal article
- Date: 2016